Publication | Open Access
Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
11
Citations
0
References
2021
Year
Chronic PhaseHematological MalignancyChronic Myeloid LeukemiaOncologyHematologyMyeloid NeoplasiaMedicineRadiation OncologyLong-term OutcomesHealth Sciences
No additional data available for this publication yet. Check back later!